Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck
- 31 October 1989
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 158 (4) , 356-360
- https://doi.org/10.1016/0002-9610(89)90133-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Indomethacin sensitive suppressor-cell activity in head and neck cancer patients: The role of the adherent mononuclear cellCancer, 1988
- Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neckCancer, 1986
- Interleukin-2 production in head and neck cancer patientsThe American Journal of Surgery, 1985
- Immunobiologic Staging of Patients with Carcinoma of the Head and NeckThe Laryngoscope, 1983
- Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapyCancer, 1982
- Immunologic Testing as a Guide to Cancer ManagementSurgical Clinics of North America, 1979
- Deficient cell‐mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cellsThe Laryngoscope, 1978
- T-cell deficiency in patients with squamous cell cancer of the head and neckThe American Journal of Surgery, 1975
- Prolonged depression of cellular immunity in cured laryngopharyngeal cancer patients treated with radiation therapyCancer, 1975
- Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neckThe American Journal of Surgery, 1974